相似文献
1
The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function.
Mol Med. 2008 May-Jun;14(5-6):235-7. doi: 10.2119/2008-00037.Fleissner.
2
Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling.
Mol Med. 2008 May-Jun;14(5-6):301-8. doi: 10.2119/2007-00052.Humpert.
3
Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks.
Eur Heart J. 2013 Jun;34(23):1755-65. doi: 10.1093/eurheartj/ehr365. Epub 2011 Sep 14.
4
A novel role for receptor activator of nuclear factor (NF)-κβ ligand (RANKL) in atorvastatin-mediated mobilization of endothelial progenitor cells.
J Mol Cell Cardiol. 2013 Jun;59:148-50. doi: 10.1016/j.yjmcc.2013.02.011. Epub 2013 Feb 28.
5
Elevation of cyclic AMP levels in mouse embryonic stem cells by insulin related peptides.
Early Pregnancy. 1996 Sep;2(3):191-6.
6
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
Circ Res. 2007 Feb 16;100(3):434-43. doi: 10.1161/01.RES.0000257912.78915.af. Epub 2007 Jan 18.
7
IGF-1 produced by cone photoreceptors regulates rod progenitor proliferation in the teleost retina.
Brain Res Dev Brain Res. 2005 Jan 1;154(1):91-100. doi: 10.1016/j.devbrainres.2004.10.009.
8
Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level.
Mol Cell Endocrinol. 2008 Dec 16;296(1-2):58-63. doi: 10.1016/j.mce.2008.07.012. Epub 2008 Jul 30.
9
MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.
Biochem Biophys Res Commun. 2017 Apr 29;486(2):414-422. doi: 10.1016/j.bbrc.2017.03.056. Epub 2017 Mar 15.
10
The quinic acid derivative KZ-41 prevents glucose-induced caspase-3 activation in retinal endothelial cells through an IGF-1 receptor dependent mechanism.
PLoS One. 2017 Aug 10;12(8):e0180808. doi: 10.1371/journal.pone.0180808. eCollection 2017.
引用本文的文献
1
Platelets of Healthy Origins Promote Functional Improvement of Atherosclerotic Endothelial Progenitor Cells.
Front Pharmacol. 2019 Apr 24;10:424. doi: 10.3389/fphar.2019.00424. eCollection 2019.
2
Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.
Stem Cells Int. 2016;2016:8340257. doi: 10.1155/2016/8340257. Epub 2016 Dec 20.
3
Particle Radiation-Induced Nontargeted Effects in Bone-Marrow-Derived Endothelial Progenitor Cells.
Stem Cells Int. 2015;2015:496512. doi: 10.1155/2015/496512. Epub 2015 May 5.
4
Protective role of insulin-like growth factor-1 receptor in endothelial cells against unilateral ureteral obstruction-induced renal fibrosis.
Am J Pathol. 2015 May;185(5):1234-50. doi: 10.1016/j.ajpath.2015.01.027. Epub 2015 Mar 14.
5
Synergism of matrix stiffness and vascular endothelial growth factor on mesenchymal stem cells for vascular endothelial regeneration.
Tissue Eng Part A. 2014 Sep;20(17-18):2503-12. doi: 10.1089/ten.TEA.2013.0249. Epub 2014 May 9.
6
Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice.
Cardiovasc Diabetol. 2014 Feb 12;13:42. doi: 10.1186/1475-2840-13-42.
7
Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.
Antioxid Redox Signal. 2011 Aug 15;15(4):933-48. doi: 10.1089/ars.2010.3502. Epub 2010 Dec 13.
本文引用的文献
1
Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling.
Mol Med. 2008 May-Jun;14(5-6):301-8. doi: 10.2119/2007-00052.Humpert.
2
Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.
Endocrinology. 2008 Jun;149(6):3148-57. doi: 10.1210/en.2007-1558. Epub 2008 Feb 21.
3
Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes.
Diabetologia. 2008 Feb;51(2):353-60. doi: 10.1007/s00125-007-0870-2. Epub 2007 Nov 27.
4
Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus.
Int J Clin Pharmacol Ther. 2007 Oct;45(10):563-7. doi: 10.5414/cpp45563.
5
Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I.
J Clin Endocrinol Metab. 2007 Nov;92(11):4172-9. doi: 10.1210/jc.2007-0922. Epub 2007 Aug 28.
6
Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches.
Eur J Clin Invest. 2007 Aug;37(8):603-6. doi: 10.1111/j.1365-2362.2007.01833.x.
7
Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.
Diabetes. 2007 Mar;56(3):666-74. doi: 10.2337/db06-0699.
8
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
Circ Res. 2007 Feb 16;100(3):434-43. doi: 10.1161/01.RES.0000257912.78915.af. Epub 2007 Jan 18.
9
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187.
10
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
J Am Coll Cardiol. 2005 Nov 1;46(9):1693-701. doi: 10.1016/j.jacc.2005.04.066. Epub 2005 Oct 10.
Zotero 插件